Referanslar

1. Suchocka Z, Swatowska J, Pachecka J, Suchocka P; RP-HPLC determnaton of Paraoxonase actvty n human blood serum; J of Pharmaceutcal and Bomedcal Analyss  2006;  42:113-119

2. Marchegan F, Marra M, Olver F, Cardell M, James RW, Boem M, Francesch C.   Paraoxonase 1: genetcs and actvtes durng agng. Rejuvenaton Res. 2008 Mar;11(1):113-27.

3. Hofer  Hofer SE, Bennetts B, Chan AK, Holloway B, Karschmkus C, Jenkns AJ, Slnk M, Donaghue KC. Assocaton between PON 1 polymorphsms, PON actvty and dabetes complcatons. J Dabetes Complcatons. 2006 20(5):322 -8.

4. Mackness MI, Harty D, Bhatnagar D, Wnocour PH, Arrol S, Ishola M, Durrngton P N. Serum paraoxonase actvty n famlal hypercholesterolaema and nsuln-dependent dabetes melltus. Atheroscleross. 1991; 86(2-3):193-9. 

5. Horoz M, Aslan M, Selek S, Koylu AO, Bolukbas C, Bolukbas FF, Celk H, Erel O.   PON1 status n haemodalyss p atents and the mpact of hepatts C nfecton. Cln Bochem. 2007;40(9-10):609-14.

6. Gur M, Aslan M, Yldz A, Demrbag R, Ylmaz R, Selek S, Erel O, Ozdogru I.  Paraoxonase and arylesterase actvtes n coronary artery dsease. Eur J Cln Invest. 2006 Nov;36(11):779-87.

7. Aslan M, Koseck M, Horoz M, Selek S, Celk H, Erel O. Assessment of paraoxonase and arylesterase actvtes n patents wth ron deficcecy aneema. Atherosclerooss. 2007 Apr;191(2):397 -402. 8. Aslan M, Nazlgul Y, Horoz M, Bolukbas C , Bolukbas FF, Gur M, Celk H, Erel O.  Serum paraoxonase -1 actvty n Helcobacter pylor nfected subjects. Atheroscleross. 2008 Jan;196(1):270-4.